On Monday Agilon Health Inc (NYSE: AGL) opened lower -0.43% from the last session, before settling in for the closing price of $2.31. Price fluctuations for AGL have ranged from $1.50 to $7.73 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 3.29% over the past five years. Company’s average yearly earnings per share was noted 43.88% at the time writing. With a float of $302.33 million, this company’s outstanding shares have now reached $413.02 million.
Let’s look at the performance matrix of the company that is accounted for 1076 employees. In terms of profitability, gross margin is -0.53%, operating margin of -5.11%, and the pretax margin is -4.23%.
Agilon Health Inc (AGL) Insider Updates
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Agilon Health Inc is 26.96%, while institutional ownership is 73.52%. The most recent insider transaction that took place on Dec 13 ’24, was worth 55,085. In this transaction Director of this company bought 25,000 shares at a rate of $2.20, taking the stock ownership to the 73,166 shares. Before that another transaction happened on Dec 11 ’24, when Company’s Director bought 25,062 for $2.01, making the entire transaction worth $50,269. This insider now owns 66,144 shares in total.
Agilon Health Inc (AGL) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.90% during the next five years compared to 3.29% growth over the previous five years of trading.
Agilon Health Inc (NYSE: AGL) Trading Performance Indicators
Check out the current performance indicators for Agilon Health Inc (AGL). In the past quarter, the stock posted a quick ratio of 1.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.62, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Agilon Health Inc (AGL)
Agilon Health Inc (NYSE: AGL) saw its 5-day average volume 3.06 million, a negative change from its year-to-date volume of 5.42 million. As of the previous 9 days, the stock’s Stochastic %D was 83.01%.
During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 5.97%, which indicates a significant decrease from 62.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.64% in the past 14 days, which was lower than the 100.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.80, while its 200-day Moving Average is $3.07. Nevertheless, the first resistance level for the watch stands at $2.39 in the near term. At $2.47, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.53. If the price goes on to break the first support level at $2.25, it is likely to go to the next support level at $2.19. Assuming the price breaks the second support level, the third support level stands at $2.11.
Agilon Health Inc (NYSE: AGL) Key Stats
There are currently 413,952K shares outstanding in the company with a market cap of 952.09 million. Presently, the company’s annual sales total 6,061 M according to its annual income of -260,150 K. Last quarter, the company’s sales amounted to 1,533 M and its income totaled 12,110 K.
